Pan W. Diminished leptin signaling can alter circadian rhythm of metabolic activity and feeding. J Appl Physiol 115: 995-1003. First published July 18, 2013 doi:10.1152/japplphysiol.00630.2013.-Leptin, a hormone mainly produced by fat cells, shows cell-specific effects to regulate feeding and metabolic activities. We propose that an important feature of metabolic dysregulation resulting in obesity is the loss of the circadian rhythm of biopotentials. This was tested in the pan-leptin receptor knockout (POKO) mice newly generated in our laboratory. In the POKO mice, leptin no longer induced pSTAT-3 signaling after intracerebroventricular injection. Three basic phenotypes were observed: the heterozygotes had similar weight and adiposity as the wild-type (WT) mice (Ͼ60% of the mice); the homozygotes were either fatter (ϳ30%), or rarely leaner (Ͻ5%) than the WT mice. By early adulthood, the POKO mice had higher average body weight and adiposity than their respective same-sex WT littermate controls, and this was consistent among different batches. The homozygote fat POKO showed significant reduction of midline estimating statistic of rhythm of circadian parameters, and shifts of ultradian rhythms. The blunted circadian rhythm of these extremely obese POKO mice was also seen in their physical inactivity, longer feeding bouts, and higher food intake. The extent of obesity correlated with the blunted circadian amplitude, accumulative metabolic and locomotor activities, and the severity of hyperphagia. This contrasts with the heterozygote POKO mice which showed little obesity and metabolic disturbance, and only subtle changes of the circadian rhythm of metabolic activity without alterations in feeding behavior. The results provide a novel aspect of leptin resistance, almost manifesting as an "all or none" phenomenon. leptin; metabolic activity; obesity; circadian rhythm; physical inactivity LEPTIN is a 16-kDa protein produced mainly by fat cells and released to the circulation. Among its diverse effects is regulation of feeding and metabolic activities. Blood leptin concentrations show a distinctive circadian rhythm, reaching a peak 2 h before light onset, similar to that of melatonin. Leptin level is entrained by meals (28, 30, 31) and regulated by gender and adiposity (20, 29) . Leptin crosses the blood-brain barrier (BBB) by a saturable transport mechanism (2), and this transport has a circadian rhythm both at the BBB and the bloodspinal cord barrier (26). Leptin resistance is a phenomenon seen in obesity and inflammation, defined as a lack of expected physiological response or cellular signaling in the presence of hyperleptinemia, often associated with saturation of leptin transport across the BBB (1). However, it is not yet clear whether leptin resistance plays a causal role in metabolic changes.
whether leptin resistance plays a causal role in metabolic changes.
Leptin binds to its specific receptor LepR to exert biological effects. Neuronal LepRb isoform signaling is essential to mediate its effect on feeding suppression, as shown by diabesity in neuronal LepRb knockout mice (7, 22) and by restoration of metabolic function in db/db mice after LepRb reconstitution (6, 9, 18) . In contrast to a catabolic role of neuronal leptin signaling, astrocytic and endothelial LepRs play counterregulatory roles in feeding and metabolic phenotype (15, 23) . Obesity is associated with inflammation and increased blood levels of adipokines. While obesity predisposes human and other primates to obstructive sleep apnea and impaired sleep quality, short sleep duration and fragmented sleep also contribute to obesity. It is known that disrupted circadian rhythms may precipitate obesity (3, 12, 32) , but it is not clear how obesity disrupts the circadian rhythm of the biological system. We propose that an important feature of metabolic dysregulation resulting in obesity is the loss of the circadian rhythm of biopotentials. This was tested in the recently generated pan-LepR knockout (POKO) mice. The results suggest that obesity and leptin resistance can lead to circadian disruption compared with the reverse.
MATERIALS AND METHODS
Generating pan-leptin receptor knockout mice. The LepR-floxed mice with loxP sites flanking exon 17 of LepR encoding the membrane juxtapositional cytoplasmic domain were generated in the lab of Dr. Streamson Chua, Jr., on a FVB background and maintained on a C57 background in the lab of Dr. Silvana Obici for more than six generations. They were further backcrossed in our laboratory with C57 mice (Jackson Laboratory, Bar Harbor, ME) until the 10th generation at the time of cross-breeding for this study. Tie2-cre recombinase transgenic mice were purchased from the Jackson Laboratory. These mice were housed and maintained at the PBRC Comparative Biology Core for more than 10 generations with food and water ad libitum in a 12:12-h light/dark regimen. The animal studies were approved by the Institutional Animal Care and Use Committee.
In an attempt to generate endothelial specific leptin receptor knockout (ELKO) mice, Tie2-cre recombinase transgenic (Tie2 (Table 1) and genomic DNA extracted from the tail as described previously (15) . However, when the female ELKO mice were again bred with male LepR floxed mice, there was embryonic deletion of the floxed exon 17 sequence of LepR (⌬17) resulting in pan-leptin receptor knockout (POKO) mice with general mutant membrane-bound LepR. Genotyping with tail genomic DNA confirmed the presence of exon 17 of LepR in these mice, despite an absence of the cre PCR product. These were POKO homozygotes, including [wt,⌬17], and [cre,⌬17] in the tail genotype. In other mice, coexisting cre and wt bands were present in cre recombinase genotyping, and ⌬17 PCR product was present in LepR genotyping. There were heterozygote mice, including [cre,wt,⌬17], [cre,floxed/floxed,⌬17], and [cre,wt/floxed,⌬17]. The presence of the ⌬17 PCR product in the absence of cre PCR product indicates a non-cell-specific deletion of LepR in all tissues (Fig. 1 ). This contrasts with the cell-specific mutation of LepR in the ELKO mice (15, 23) .
Lack of leptin-induced pSTAT3 activation shown by Western blotting (WB).
After overnight fasting, 3-mo-old male POKO, ELKO, and their wild-type (WT) littermates were injected with mouse recombinant leptin (R&D Systems, Minneapolis, MN) dissolved in phosphatebuffered saline (PBS) or with vehicle between 1:00 pm and 2:00 pm either intraperitonealy (ip, 3 mg/kg) or through intracerebroventricular (icv) delivery (2.5 g/l per mouse) under anesthesia (urethane, 1 g/kg). At 45 min after leptin ip or 30 min after leptin icv, the mice were killed and the hypothalamus and cortex were dissected on ice followed by snap-freezing in liquid nitrogen. The frozen tissues were stored at Ϫ80°C until use.
Total protein was extracted from tissue by sonication in icy cold RIPA buffer containing protease inhibitor and phosphatase inhibitor cocktail (Thermo Scientific, Rockford, IL). The homogenate was centrifuged at 18,000 g at 4°C for 15 min. The supernatant was transferred to a new tube and the protein concentration was determined by Pierce BCA Protein Assay Kit (Thermo Scientific). Fifty micrograms of total protein from each sample was mixed with adequate amount of Laemmli sample buffer (Bio-Rad, Hercules, CA), boiled for 5 min, and then loaded to 8.5% SDS-PAGE for electrophoresis. Afterwards, the proteins on the SDS-PAGE were transferred to 0.45 m nitrocellulose membrane (Bio-Rad) for WB. The nitrocellulose membrane was blocked in 5% BSA and was incubated with anti-pSTAT3 (Tyr 705) primary antibody (1:1,000, Cell Signaling Technology, Boston, MA) at 4°C overnight and then with horseradish peroxidase (HRP)-conjugated secondary antibody (1:5,000) at room temperature for 1 h. The signal of pSTAT3 was developed on an X-ray film after incubation with nitrocellulose membranes in Pierce ECL Western Blotting Substrate (Thermo Scientific). After antipSTAT3 antibody was stripped off with Restore Western Blot Stripping Buffer (Thermo Scientific), the same blot was used to determine total STAT3 level with anti-STAT3 antibody (1:2,000, Cell Signaling Technology) following the same procedure as for pSTAT3. The amount of expressed pSTAT3 and STAT3 was quantified by NIH ImageJ software. The expression level of pSTAT3 was normalized to the level of total STAT3 for statistical comparison (n ϭ 2/group).
Metabolic chambers and cosinor analysis of metabolic activities. The POKO and WT littermates of both sexes were weighed weekly and their body fat (%body wt) was measured monthly in a Bruker Minispec live mouse analyzer (Bruker Optics, The Woodslands, TX). At 19 wk of age, the mice were subjected to metabolic chamber studies as described previously (13, 23) .
The metabolic profile of the mice was determined by Oxymax open-circuit calorimeter (Columbus Instruments, Columbus, OH). After acclimation of the mice to the Oxymax setup for 3 days, 7 variables [oxygen consumption (V O2), carbon dioxide production (V CO2), respiratory exchange ratio (RER), heat dissipation (Heat), total activity at x-axis (XTOT), ambulation at x-axis (XAMB), and total activity at z-axis (ZTOT)] were sampled every 18 min for another 3 days from 13 WT (9 male, 4 female) and 10 POKO (5 male, 5 female) mice (n ϭ 237 time points). Among the latter, 1 male (M344) and 1 female (F353) differed from the others by being excessively obese. Differences between males and females in each group were plotted as a function of time as were differences between WT and POKO mice of each sex. For each animal, the accumulated metabolic activities in each light and dark cycle in 3 days were calculated separately and averaged. The results of these accumulated metabolic parameters in light and dark cycle in each group were compared by Student's t-test.
The circadian parameters in the metabolic profile were assessed by the cosinor analysis that models the circadian rhythms as a cosine function with the following attributes: amplitude (half of the extent that the cosine wave oscillates), midline estimating statistic of rhythm (MESOR, the mean value of the peak and nadir between which the predicted cosine wave oscillates), acrophase (the elapsed time from 12:00 am to reach the peak value of the cosine wave within a period), and period (the duration of one cycle), as described previously (4, 27) .
The predicted models for current metabolic data can be expressed as the following cosine function and illustrated as in Fig. 2 :
where M is MESOR, A is amplitude, t is elapsed time, is period, and is acrophase. The predicted cosine functions of individual records were acquired by least-squares analysis in the frequency range of one cycle in 3 days to 24 cycles per day for each variable. Phase-unweighted average spectra were obtained by averaging cosine function attributes at each trial period for each sex in each group (WT and POKO). Student's t-test compared amplitudes, MESOR, and acrophase of each variable between groups at a given trial period for sex and KO differences. The 90% prediction limits were also computed. Population-mean cosinor spectra were obtained for each group and variable in the frequency range of 1-24 cycles per day. Parameter tests were performed to assess sex and group differences for the first 5 harmonic terms with periods of 24, 12, 8, 6 , and 4.8 h.
Measurement of food intake. Groups of POKO and WT mice (n ϭ 10/group, mixed sexes, excluding the two extremely obese mice that could not access the food chamber) were adapted to single housing for 3 days in BioDaq cages (Research Diets, New Brunswick, NJ), and food measurement was monitored for 10 days. The accumulated food intake in each hour in the dark cycle and in the light cycle was compared.
Statistical analyses. Group means were expressed with their standard errors. Two-way analysis of variance (ANOVA) with repeated measures on one factor was used to analyze the results of body weight and fat composition measured over time. Two-way ANOVA followed by Bonferroni's posttest was used to analyze WB results. Cosinor analysis for circadian rhythm data and analysis of other metabolic activity results were described in the metabolic chamber section above. For other nonrhythmic data with cross-sectional measures, when more than two groups were compared, one-way ANOVA was performed, followed by Tukey's post hoc test. When two groups were compared, an unpaired t-test was performed. SPSS or GraphPad Prism 5 was used for statistical analysis.
RESULTS

Characterization of the specificity and efficiency of POKO.
The POKO mice were first identified from tail genotyping while breeding female ELKO mice with male LepR floxed mice. In Fig. 1, lanes 1 and 2 are from ELKO mice, lane 3 from a WT mouse, and lanes 4 and 5 from POKO mice. In the WT mouse, tail genomic DNA did not contain Tie2-cre transgene (lane 3, Fig. 1A) . One of the two loxP sites close to the 5=-end of exon 17 of LepR was still detectable and no deletion of exon 17 occurred (lane 3, Fig. 1B ). In the ELKO mice, the Tie2-cre transgene was present (lanes 1 and 2, Fig. 1A ), but part of the exon 17 of LepR had already been excised and the gel image of the PCR product shows a ⌬17 band. This probably resulted from endothelial cells in the tail. Concurrently, there remained loxP-flanked LepR at a higher molecular weight than the ⌬17 band (lanes 1 and 2, Fig. 1B ). In the homozygote POKO mice, by contrast, the ⌬17 band was present (Fig. 1B) regardless of the existence of Tie2-cre (Fig. 1A, lanes 4 and 5) .
The percentage of functional membrane-bound LepR remaining in POKO brains was assessed by the ability of leptin to activate STAT3 signaling in the hypothalamus of the brain. When leptin was given ip at the dose of 3 mg/kg, the pSTAT3 level in the hypothalamus was increased in WT, ELKO, and POKO compared with vehicle-only groups (F 1,6 ϭ 16.20, P ϭ 0.007). However, leptin-induced pSTAT3 level was not influenced by the different genetic background (F 2,6 ϭ 0.75, P ϭ 0.514), suggesting the presence of secondary mediators (Fig.  3A) . When 2.5 g of leptin was delivered directly into the brain by icv injection to avoid potential peripheral interference, the level of leptin-induced pSTAT3 in hypothalamus was dependent on the genetic background (F 2,6 ϭ 104.33, P Ͻ 0.0001). WT and ELKO mice both showed a significant increase of pSTAT3 in the hypothalamus (P Ͻ 0.0001). However, the POKO mice failed to show an increase of pSTAT3 upon leptin stimulation. The level of induced pSTAT3 was highest in WT hypothalamus and lowest in POKO hypothalamus (Fig. 3B) . Cerebral cortex did not respond to leptin stimulation as strongly as hypothalamus in all three groups when leptin was given either ip (F 1,6 ϭ 0.69, P ϭ 0.437) or icv (F 1,6 ϭ 0.02, P ϭ 0.900), consistent with a relatively low level of LepRb there (Fig. 3, C and D) .
Body weight and adiposity in POKO mice. Four groups of mice were studied: WT male (n ϭ 9), POKO male (n ϭ 5), WT female (n ϭ 4), and POKO female (n ϭ 5). Body weight was measured weekly starting from age 5 wk (Fig. 4A) . In general, body weight increased over time regardless of genotype and sex (F 15,285 ϭ 84.28, P Ͻ 0.0001), and different genotype and sex had different growth curves (F 3,19 ϭ 6.09, P ϭ 0.004). In WT mice, male mice had higher body weight than female mice in general (F 1,11 ϭ 24.80, P ϭ 0.0004), and the sex factor significantly affected the weight gain over time (F 15,165 ϭ 4.27, P Ͻ 0.0001), indicating that the male mice gained weight faster than the female mice. Such interaction of sex and time in weight gain was not seen in POKO mice (F 15,120 ϭ 0.23, P ϭ 0.999), and neither sex of POKO differed from each other in body weight (F 1,8 ϭ 0.93, P ϭ 0.363). Comparison of the body weight of WT and POKO of the same sex showed that the body weight of male POKO mice was generally heavier than that of male WT (F 1,12 ϭ 11.20, P ϭ 0.006), and these male POKO gained weight slightly, but not significantly, faster over time than male WT (F 15,180 ϭ 1.68, P ϭ 0.058). Similarly, although without statistical significance, the body weight of female POKO was also heavier than that of female WT overall (F 1,7 ϭ 5.05, P ϭ 0.059). However, there was no interaction between genotype and time factor in female mice (F 15,105 ϭ 0.97, P ϭ 0.49), which indicates that the two growth curves of female WT and POKO are parallel to each other. At the end of the study, it was apparent that the POKO group was heteroge- neous; about one-third of POKO male and 30% of POKO female were significantly heavier than other mice in the same group (Fig. 4B) . This trend was consistent among different batches of mice. Overall, the heterozygotes had similar weight and adiposity as the WT mice (Ͼ60% of the mice); the homozygotes were either fatter (ϳ30%), or rarely leaner (Ͻ5%) than the WT mice. Among the fat POKO, those with a genotype of [wt,⌬17] were heavier than [cre,⌬17].
The percent fat in the body was measured every 4 wk during the ages of 13-24 wk (Fig. 4C) . Since there was no sex difference in fat composition at this age bracket in WT (F 1,6 ϭ 0.57, P ϭ 0.479) or in POKO (F 1,5 ϭ 0.04, P ϭ 0.848), the data from both sexes were combined for comparison between WT and POKO. Overall, POKO mice had higher fat composition than WT mice (F 1,13 ϭ 21.87, P ϭ 0.0004). Compared with the baseline at week 13, only the WT group had a significant increase of percent fat over time, at week 24 (t ϭ 2.87, P Ͻ 0.05). More pronounced differences were observed for the fat POKO mice. Both male and female fat POKO mice had a lower MESOR of V O 2 , V CO 2 , and XAMB and a higher MESOR of Heat. They also had a smaller 24-h amplitude of RER. In addition, the female fat POKO mouse had a lower 24-h amplitude of V O 2 , V CO 2 , Heat, and XAMB. These differences were statistically significant as they exceeded the 90% prediction limits of the WT mice and/or their non-fat POKO counterparts.
The representative least-squares spectra of V O 2 ( Fig. 5A ) and XTOT horizontal activity (Fig. 5B) , and their respective MESOR (Fig. 5C) , are shown.
Food intake. BioDaq data analysis detected differences of food intake in WT and POKO mice in regard to accumulated meal count (Fig. 6A) , averaged meal size (Fig. 6B) , and accumulated food intake (Fig. 6C ) in every light/dark cycle. The sex difference in these parameters in either WT or POKO was not significant [accumulated food intake: F WT(1,152) ϭ 1.09, P ϭ 0.327; F POKO(1,114) ϭ 0.22, P ϭ 0.659; averaged meal size: F WT(1,152) ϭ 2.23, P ϭ 0.174; F POKO(1,114) ϭ 1.30, P ϭ 0.298; accumulated food intake: F WT(1,152) ϭ 3.80, P ϭ 0.087; F POKO(1,114) ϭ 1.56, P ϭ 0.258]. Therefore, comparisons between WT and POKO were made on the data with mixed sexes. The total food intake in 10 days is shown in Fig. 6D . Although food intake was similar between WT and heterozygote POKO, the homozygote POKO mice showed longer feeding bouts and higher food intake, although statistical evaluation was limited by the small sample size.
DISCUSSION
In this study we showed the loss of leptin signaling at its brain targets in POKO mice, the correlation of metabolic phenotype and hyperphagic feeding behavior with genotype, and a striking stratification of dampened circadian rhythm of the obese POKO mice compared with their heterozygous and WT littermates. A complete loss of leptin signaling in all cells led to the most pronounced obesity and altered circadian and ultradian rhythm of metabolic activities and feeding.
There are five isoforms of LepR in mice, showing differential expression in different cell types and regions. The effect of leptin on feeding regulation in normal animals is commonly thought to be mediated by LepRb in neurons, particularly in the arcuate nucleus in hypothalamus (10) . In mice with adult-onset obesity, the expression of LepR shifts from a predominant neuronal distribution to a heightened astroglial expression in the hypothalamus. Obesity induces reactive astrogliosis and upregulation of astrocytic LepR (14, 24) , suggesting that nonneuronal leptin signaling may play a functional role in metabolic activities.
To determine the role of cell-specific leptin signaling at the BBB level, we have generated ELKO as well as astrocytic specific LepR knockout mice with a cre-loxp breeding strategy (15) and showed their counterregulatory effects as opposed to neuronal leptin signaling in diet-induced obesity (16, 23) . In these tissue-specific LepR knockout mice, the target cells (astrocytes or endothelial cells) express a mutant, membranebound LepR that does not have any signaling function because the cytoplasmic tail containing Box I, II, and III was completely removed as a result of excision of loxP-flanked exon 17 by cell-type specific expression of Cre recombinase (15, 21) . Unexpectedly, the cre-loxP breeding scheme also generated POKO mice when the female ELKO mice were backcrossed with male LepR floxed mice on a C57 background. The expression of mutant, membrane-bound LepR in the new strain of POKO mice was not dependent on the presence of Cre recombinase, indicating a loss of tissue specificity of the LepR mutation (Fig. 1 ). This differs from most known mutant mice related to leptin and its receptors. For example, db/db mice have a mutant long isoform of LepRb but other receptor subtypes remain intact (5, 19) , whereas ob/ob mice are leptindeficient (8, 11) . This is similar to a report of two out of three strains of LepR mutant mice without signaling domain that have not been used widely (17) . The newly generated POKO mice, therefore, offer a useful tool to determine how obesity resulting from the absence of leptin signaling in all cells modulates the circadian rhythm of metabolic activities and feeding behavior.
To confirm the efficiency and completeness of LepR mutation in all cells, we followed genotyping results with leptininduced pSTAT3 activation. Although LepRb is the only receptor isoform able to mediate STAT3 activation, the loss of pSTAT3 signaling in response to leptin icv in the POKO mice contrasts with the persistence of leptin signaling in WT and ELKO mice. Unlike ELKO mice that have similar weight and percent fat as their WT littermates (23), POKO mice had significantly higher average body weight and adiposity. Among the POKO mice, the homozygote [wt,⌬17] was the most obese, followed by the homozygote [cre,⌬17]. By contrast, all heterozygotes had similar weight and percent fat as the WT littermates. There appeared to be a threshold effect of the loss of leptin signaling. Blood leptin concentration correlates with adiposity and is entrained by meal as well as circadian rhythm. It has a peak 2 h before light onset in humans and shows differences related to sex and developmental stage (20, 25, 26, 29) . Disrupted circadian rhythm promotes obesity and insulin resistance (32) . Here, we showed that obese POKO mice had attenuated circadian rhythms of metabolic parameters. It is yet to be determined whether obesity and/or hyperleptinemia played a causal role. Nonetheless, acute leptin treatment by intraperitoneal injection did not induce chronic modification of metabolic profile (data not shown). There were also lengthy bouts of eating with reduced bout counts both night and day, resulting in greater accumulative food intake. The greater difference of food intake between the fat POKO and the lean POKO and WT groups at the beginning of the BioDaq study (in contrast to that toward the end of the 10-day trial) also suggests that the fat POKO mice probably showed greater susceptibility to stress, such as caused by adaptation to new cages.
In summary, the obese POKO mice had blunted circadian rhythms of metabolic activities and showed hyperphagia across the circadian span. There was a threshold effect, in that homozygote POKO mice showed greater disturbance of weight and fat homeostasis and a dampened circadian rhythm. The results add a novel aspect of leptin resistance in obesity, and also present a clear example of obesity blunting the circadian rhythm of biopotentials, causing rather than resulting from the diminished rhythm.
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